63.2% of matchups won
863 matchups
Elo 1584
tracked 2025/06/05 → 2026/10/26
mission: Innovating life-saving therapies · Biotechnology and Pharmaceuticals · companies · company in nasdaq 100 · company in fortune 500 · company in s and p 500
Public sentiment
how often it gets picked, by matchup framing61%
picked as helping wellbeing
698 matchups
71%
picked as hurting wellbeing
165 matchups
On balance people see it as hurting.
Who rates it higher
See who rates Regeneron Pharmaceuticals higher
The 3 splits (party, gender, age, US vs. international) are free with an email. No password.
Rating over time
Elo, 7-day average · history as of 2025-08-29Related
Similar organizations
01
Amgen
→
39.4% wins · American multinational biopharmaceutical company
02
Pfizer
→
54.1% wins · American multinational pharmaceutical corporation
03
BeiGene
→
66.8% wins · company in Cambridge, Massachusetts, USA.
04
Merck & Co.
→
54.3% wins · American multinational pharmaceutical company
05
AstraZeneca
→
43.6% wins · British-Swedish pharmaceutical company
Known for
- Developed COVID-19 treatment
- Created effective eye therapy
- Collaboration with Sanofi
- Acquired Checkmate Pharmaceuticals
- Listed in Dow Jones Sustainability
Based on 863 head-to-head matchups from Mic Check's global survey; ratings use Elo (1500 = neutral start). Latest data 2026/10/26. Full rankings ·
Want the full story?
Tracking over time, custom demographic cuts, benchmarking and message testing.
Commission a study →